- Home
- PRTA vs IMOS Comparison
PRTA vs IMOS Comparison
Compare PRTA & IMOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- IMOS
- Stock Information
- Founded
- PRTA 2012
- IMOS 1997
- Country
- PRTA Ireland
- IMOS Taiwan
- Employees
- PRTA N/A
- IMOS N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- IMOS Semiconductors
- Sector
- PRTA Health Care
- IMOS Technology
- Exchange
- PRTA Nasdaq
- IMOS Nasdaq
- Market Cap
- PRTA 802.8M
- IMOS 813.1M
- IPO Year
- PRTA N/A
- IMOS N/A
- Fundamental
- Price
- PRTA $13.41
- IMOS $19.15
- Analyst Decision
- PRTA Buy
- IMOS
- Analyst Count
- PRTA 7
- IMOS 0
- Target Price
- PRTA $57.67
- IMOS N/A
- AVG Volume (30 Days)
- PRTA 448.2K
- IMOS 27.3K
- Earning Date
- PRTA 11-12-2024
- IMOS 11-05-2024
- Dividend Yield
- PRTA N/A
- IMOS 6.10%
- EPS Growth
- PRTA N/A
- IMOS 7.03
- EPS
- PRTA N/A
- IMOS 0.07
- Revenue
- PRTA $133,350,000.00
- IMOS $724,842,895.00
- Revenue This Year
- PRTA $46.28
- IMOS $15.65
- Revenue Next Year
- PRTA N/A
- IMOS $13.49
- P/E Ratio
- PRTA N/A
- IMOS $12.84
- Revenue Growth
- PRTA N/A
- IMOS 13.31
- 52 Week Low
- PRTA $12.31
- IMOS $18.20
- 52 Week High
- PRTA $41.55
- IMOS $32.19
- Technical
- Relative Strength Index (RSI)
- PRTA 43.50
- IMOS 42.28
- Support Level
- PRTA $12.31
- IMOS $18.20
- Resistance Level
- PRTA $14.28
- IMOS $19.40
- Average True Range (ATR)
- PRTA 0.98
- IMOS 0.24
- MACD
- PRTA 0.00
- IMOS 0.01
- Stochastic Oscillator
- PRTA 33.73
- IMOS 55.88
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. The Company derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.